Sign in

You're signed outSign in or to get full access.

Margaret Wolff

About Margaret L. Wolff

Margaret L. Wolff is an independent director of Nuveen Taxable Municipal Income Fund (NBB) serving on Nuveen’s unitary board since 2016; she is a former Skadden, Arps M&A lawyer with over 30 years advising boards on governance and fiduciary matters. She holds a BA from Mount Holyoke College and a JD from Case Western Reserve University School of Law; born in 1955, she is currently a Class I nominee at NBB for a term expiring at the 2028 annual meeting.

Past Roles

OrganizationRoleTenureCommittees/Impact
Skadden, Arps, Slate, Meagher & Flom LLPOf Counsel, M&A Group2005–2014Advised boards and senior management on governance, shareholder, fiduciary, regulatory, and strategic matters
Travelers Insurance Company of Canada; The Dominion of Canada General Insurance Company (subsidiaries of Travelers Canada)Director2013–2017Oversight roles at Canadian subsidiaries of a public insurance group
Mount Holyoke CollegeTrustee; Vice Chair of the BoardTrustee 2005–2015; Vice Chair 2011–2015Board leadership and governance at a higher-education institution

External Roles

OrganizationRoleTenureNotes
New York-Presbyterian HospitalTrusteeSince 2005Ongoing non-profit healthcare governance role
The John A. Hartford FoundationTrustee; Chair (former)Trustee since 2004; Chair 2015–2022Philanthropy focused on care of older adults

Board Governance

  • Independence: The Nuveen funds’ boards designate Wolff and all nominees as “Independent Board Members”; none have been employees or directors of TIAA, Nuveen, or affiliates.
  • Committee assignments (NBB/Unitary Board):
    • Compliance, Risk Management & Regulatory Oversight Committee: Chair
    • Audit Committee: Member
    • Nominating & Governance Committee: Member
    • Investment Committee: Member
    • Closed-End Fund Committee: Member
    • Not on Executive or Dividend Committees (current rosters exclude Wolff)
  • Election class/term: For NBB, Wolff is a Class I nominee in 2025 for a term expiring at the 2028 annual meeting.
  • Attendance: Each Board Member attended at least 75% of Board and applicable committee meetings in the last fiscal year.
  • Board leadership: Robert L. Young serves as Independent Chair of the Board.
  • NBB meeting cadence (FY ended March 31, 2025): Regular Board 4; Special Board 7; Executive 3; Dividend 8; Compliance 4; Audit 14; Nominating & Governance 6; Investment 4; Closed-End Fund 4.

Fixed Compensation

Component (Independent Board Members)Amount (USD)Effective DateNotes
Annual base retainer$350,000Jan 1, 2025Paid across Fund Complex; allocated among funds
Audit Committee membership retainer$35,000Jan 1, 2025Per committee membership
Compliance Committee membership retainer$35,000Jan 1, 2025Per committee membership; Wolff is also Chair
Investment Committee membership retainer$30,000Jan 1, 2025Per committee membership
Nominating & Governance membership retainer$25,000Jan 1, 2025Per committee membership
Closed-End Fund Committee membership retainer$25,000Jan 1, 2025Per committee membership
Compliance Committee Chair fee$35,000Jan 1, 2025Chair premium for committee leadership
Ad hoc meetings$1,000 or $2,500 per meetingJan 1, 2025Based on length/immediacy
Special assignment committeesChair quarterly fee from $1,250; members from $5,000Jan 1, 2025As applicable
Deferred Compensation PlanElected deferrals credited to fund-linked accountsOngoingLump sum or 2–20 year distributions; plan mechanics detailed
FundPeriodAggregate Compensation Paid to Wolff (USD)
NBB (Taxable Income)FY ended Mar 31, 2025$2,033
All Nuveen Funds (Fund Complex)Latest disclosed$502,381
FundPeriodDeferred Fees Credited to Wolff (USD)
NBB (Taxable Income)FY ended Mar 31, 2025$622

Performance Compensation

Variable Pay ElementStatusPerformance MetricsNotes
Performance-based bonus/equity (RSUs/PSUs/options)None disclosedN/AIndependent directors receive cash retainers, committee fees, and may elect deferral; no performance metrics specified for director compensation.

Other Directorships & Interlocks

Company/InstitutionPublic/PrivateRolePotential Interlock/Conflict
Travelers Insurance Company of Canada; The Dominion of Canada General Insurance Company (Travelers Canada subsidiaries)Subsidiaries of public companyDirector (2013–2017)No NBB-related transactions disclosed; historical role at Canadian subsidiaries of Travelers.
New York-Presbyterian HospitalNon-profitTrustee (since 2005)No related-party transactions disclosed in NBB proxy.
The John A. Hartford FoundationNon-profitTrustee; Chair 2015–2022No related-party transactions disclosed in NBB proxy.
  • Related-party transactions: The proxy’s “Board Member Investments in Companies” section lists common-control holdings for Thomas J. Kenny; no related-party holdings or transactions are attributed to Wolff.

Expertise & Qualifications

  • Legal/governance expertise: Decades advising boards and executives on U.S. and international corporate, securities, regulatory, governance, shareholder, and fiduciary matters during tenure at Skadden’s M&A group.
  • Sector breadth: Experience spans healthcare and philanthropy through trusteeships at New York-Presbyterian Hospital and The John A. Hartford Foundation.
  • Governance credentials: Prior board leadership at Mount Holyoke (Vice Chair), and past directorships at insurance subsidiaries, supporting oversight acumen.
  • Audit Committee financial expert: Not designated; committee members with “financial expert” status are Boateng, Nelson, Starr, and Young.

Equity Ownership

Holding CategoryNBB (Taxable Income)Aggregate Across Nuveen Fund Complex
Dollar range of equity securities beneficially owned$0 Over $100,000
Shares beneficially owned0 Not individually enumerated; aggregate category provided
Ownership % of outstanding shares<1% for each Board Member per fund (general statement) N/A
  • Ownership alignment policy: Nuveen boards expect each Board Member to invest at least one year of compensation in the funds in the Fund Complex; board members and officers as a group own <1% of outstanding shares of each fund.

Governance Assessment

  • Strengths:
    • Independent status and absence of TIAA/Nuveen affiliation enhances board objectivity.
    • Chair of the Compliance Committee with broad remit over compliance, risk management, leverage/derivatives oversight, and enterprise risk—signals deep engagement in risk controls.
    • Member of Audit, Nominating & Governance, Investment, and Closed-End Fund committees—broad oversight footprint across financial reporting, board processes, performance, and discount/leverage strategy.
    • Attendance threshold met (≥75% of meetings), supporting engagement.
  • Compensation and incentives:
    • Compensation is cash-based with committee retainers and chair premiums; no equity grants or performance metrics for directors, reducing misaligned incentive risk in this fund governance context.
    • Deferred compensation elections are indexed to Nuveen funds, providing economic alignment with fund outcomes while not constituting equity awards.
  • Potential risk indicators and red flags:
    • $0 beneficial ownership and 0 shares in NBB specifically may be viewed as a weaker “skin-in-the-game” signal at the individual fund level, despite aggregate holdings “Over $100,000” across the complex and a guideline to invest at least one year of compensation; compliance with the guideline is not disclosed.
    • No related-party transactions, pledging/hedging, tax gross-ups, or option repricing disclosed for Wolff—no conflicts flagged in the proxy.
  • Overall implication:
    • Wolff’s deep governance/legal background and chairing of the Compliance Committee support board effectiveness and investor confidence, while the absence of NBB-specific ownership is a neutral-to-slightly negative alignment signal that is partially offset by aggregate complex-level investment and the deferred compensation structure.